60 Degrees Pharmaceuticals, Inc.
SXTP
$2.87
-$0.043-1.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.95% | 76.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.95% | 76.50% | |||
| Cost of Revenue | 146.82% | -197.66% | |||
| Gross Profit | -117.43% | 242.61% | |||
| SG&A Expenses | 5.05% | 32.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.28% | 3.11% | |||
| Operating Income | 7.94% | 2.02% | |||
| Income Before Tax | 8.40% | 5.13% | |||
| Income Tax Expenses | 120.00% | -266.67% | |||
| Earnings from Continuing Operations | 8.38% | 5.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -79.49% | 457.14% | |||
| Net Income | 8.24% | 5.32% | |||
| EBIT | 7.94% | 2.02% | |||
| EBITDA | 8.05% | 2.10% | |||
| EPS Basic | 31.73% | 51.13% | |||
| Normalized Basic EPS | 31.62% | 51.62% | |||
| EPS Diluted | 31.73% | 51.13% | |||
| Normalized Diluted EPS | 31.62% | 51.62% | |||
| Average Basic Shares Outstanding | 34.29% | 95.62% | |||
| Average Diluted Shares Outstanding | 34.29% | 95.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||